ARTICLE | Company News
BioVisioN, ImVisioN GmbH deal
May 30, 2005 7:00 AM UTC
ImVisioN acquired rights to BioVision's IP covering the MAT (Modular-Antigen-Transport) technology. ImVisioN also acquired exclusive rights to a patent application covering the recombinant expression ...